A novel rat lipoxin A4 receptor that is conserved in structure and function
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Lipoxin (LX) A 4 and aspirin‐triggered‐LX (ATL) are endogenous lipid‐derived mediators that regulate leukocyte trafficking via specific LXA 4 receptors (ALX), and are involved in endogenous anti‐inflammation and resolution. Both LXA 4 and ATL are produced by rat tissues in vitro as well as in vivo. In rats, LXA 4 and ATL exhibit potent physiological and pathophysiological roles. Thus, we set out to determine whether ALX is expressed in rat tissues and its potential role in modulating leukocyte trafficking with LXA 4 and ATL. In rats, a stable analog of ATL, when given intravenously with two consecutive doses at approximately 60 μ g kg−1 each injection, significantly inhibited neutrophil infiltration (∼43%) and protein extravasation (∼42%) in a casein‐induced peritonitis. The rat orthologue of ALX was cloned from peripheral blood leukocytes encoding a putative G protein‐coupled receptor (GPCR). It gave ∼74 and ∼84% homology, respectively to the deduced amino‐acid sequences of the human and mouse ALX. Tissue distribution analysis by RNase protection revealed that this rat receptor is expressed in tissues/cells, where LXA 4 displays physiological and pathophysiological roles, namely, lung, kidney and leukocytes. The rat orthologue of ALX gave specific radioligand binding with [3 H]LXA 4 and [125‐Tyr]‐annexin 1‐derived peptide with apparent Kd values of 5 and 820 n M, respectively, that are at levels comparable to those of the human ALX. Activation of rat ALX inhibited tumor necrosis factor alpha‐mediated nuclear factor kappaB activity in a ligand‐dependent manner utilizing a luciferase reporter gene system. Together, these results are the first demonstration of a rat ALX that is conserved in both structure and function suggesting that ALX plays key roles in regulating effector immune responses from murine to human species. British Journal of Pharmacology (2003) 139, 89–98. doi:10.1038/sj.bjp.0705220
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“We and others have demonstrated that LXA4 and ATL inhibit release of select ‘proinflammatory cytokines’ (Hachicha et al., 1999) and promote resolution (Godson et al., 2000; Levy et al., 2001).”
BackgroundSelf-citationGodson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Mitchell, S., Thomas, G., Harvey, K., Cottell, D., Reville, K., Berlasconi, G., Petasis, N. A., Erwig, L., Rees, A. J., Savill, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032417.73640.72 · Cited by 287
Cited by
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology
Buczynski, M. W., Dumlao, D. S., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900004-jlr200 · Cited by 530
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Self-citationMIGEOTTE, I., COMMUNI, D., & PARMENTIER, M. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.009 · Cited by 457
Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
Serhan, C. N., & Chiang, N. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707489 · Cited by 431
Self-citationNatural resolution of inflammation
Freire, M. O., & Van Dyke, T. E. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 388
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Resolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
Self-citationDHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 286
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
N. Serhan, C., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 276
Self-citationAnti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX
Chiang, N., Arita, M., & Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.003 · Cited by 239
Self-citationLipoxins and aspirin-triggered lipoxins in resolution of inflammation
Romano, M., Cianci, E., Simiele, F., & Recchiuti, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.083 · Cited by 183
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
“LXA4 and 15-epi-LXs elicit their multi-cellular responses via ALX (FPRL1 receptor), a specific G-protein-coupled receptor (GPCR) isolated and cloned in human, mouse and rat tissues (220-222).”
BackgroundAnnexin A1 regulates intestinal mucosal injury, inflammation, and repair
Babbin, B. A., Laukoetter, M. G., Nava, P., Koch, S., Lee, W. Y., Capaldo, C. T., Peatman, E., Severson, E. A., Flower, R. J., Perretti, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5035 · Cited by 134
“and contains at least nine family members (42, 62).”
BackgroundChiang, N., & Serhan, C. N. (2006) · Comprehensive Therapy · doi:10.1007/s12019-006-0005-6 · Cited by 17
Self-citation
Metadata
- Authors
- Chiang, N., Takano, T., Arita, M., Watanabe, S., & Serhan, C. N.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 139
- Issue
- 1
- Pages
- 89-98
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2050045837
- Cited by
- 91
- References
- 3
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.